Literature DB >> 16808547

Evaluating Diagnosis and Treatment Patterns of COPD in Primary Care.

Vijay N Joish1, Ellen Brady, William Stockdale, Diana I Brixner, Riad Dirani.   

Abstract

OBJECTIVE: Many patients with COPD are misdiagnosed or under-treated. The characteristics of COPD patients and the patterns of treatment have not been well characterized in primary care settings. The objective of this study was to identify patterns of COPD onset, diagnosis and treatment with the goal of facilitating appropriate treatment at earlier stages.
METHODS: A national electronic medical record database was used to identify patients with at least a 6-month history prior to a diagnosis of COPD (ICD-9 codes 491.xx, 492.xx, and 496). Pulmonary function test (PFT) results closest to the first diagnosis of COPD were evaluated to characterize disease severity using the Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria. Prescription data were evaluated at the time of diagnosis. All descriptive statistics were conducted using STATA statistical software.
RESULTS: A total of 14 691 patients met the study criteria. Prescription data were available for 9354 (64%) of these patients. Of this group, only slightly over 50% (n = 5264) had a respiratory-related prescription on the date of diagnosis. For those not having a respiratory drug at the time of diagnosis, the average time between diagnosis and the first respiratory-related prescription was 106 (SD +/- 256.4) days. Only 389 (<3%) patients had any PFT data recorded on or prior to the day of their first diagnosis of COPD, and only 273 (2%) had sufficient PFT data available to determine their GOLD severity class. The average time between diagnosis and first COPD prescription was greatest for patients in the lowest severity category (Class 0/I; 163 +/- 288.2 days), and smallest for patients in the highest severity category (Class IV; 124 +/- 152.3 days).
CONCLUSION: COPD is often not diagnosed or treated until the later stages of disease, and spirometry is not used routinely to diagnose, stage or guide treatment decisions.

Entities:  

Mesh:

Year:  2006        PMID: 16808547     DOI: 10.2165/00151829-200605040-00006

Source DB:  PubMed          Journal:  Treat Respir Med        ISSN: 1176-3450


  8 in total

1.  Factors predictive of airflow obstruction among veterans with presumed empirical diagnosis and treatment of COPD.

Authors:  Bridget F Collins; Laura C Feemster; Seppo T Rinne; David H Au
Journal:  Chest       Date:  2015-02       Impact factor: 9.410

Review 2.  Improving the differential diagnosis of chronic obstructive pulmonary disease in primary care.

Authors:  David B Price; Barbara P Yawn; Rupert C M Jones
Journal:  Mayo Clin Proc       Date:  2010-12       Impact factor: 7.616

3.  Prevalence of users of medication targeting obstructive lung disease, the reasons for prescriptions and the use of spirometry in Upernavik Health Center in the period from 2011-2016, a retrospective observational study as basis for future quality development.

Authors:  Hans Kallerup; Mette Bordinggaard Brøndserud
Journal:  Int J Circumpolar Health       Date:  2022-12       Impact factor: 1.228

4.  Assessment of COPD-related outcomes via a national electronic medical record database.

Authors:  Carl Asche; Quayyim Said; Vijay Joish; Charles Oaxaca Hall; Diana Brixner
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008

5.  Primary care physician perceptions on the diagnosis and management of chronic obstructive pulmonary disease in diverse regions of the world.

Authors:  Zaurbek Aisanov; Chunxue Bai; Otto Bauerle; Federico D Colodenco; Charles Feldman; Shu Hashimoto; Jose Jardim; Christopher K W Lai; Rafael Laniado-Laborin; Gilbert Nadeau; Abdullah Sayiner; Jae Jeong Shim; Ying Huang Tsai; Richard D Walters; Grant Waterer
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2012-04-05

6.  The clinical and economic burden of chronic obstructive pulmonary disease in the USA.

Authors:  Anthony J Guarascio; Shauntá M Ray; Christopher K Finch; Timothy H Self
Journal:  Clinicoecon Outcomes Res       Date:  2013-06-17

7.  Prevalence and management of patients using medication targeting obstructive lung disease: a cross-sectional study in primary healthcare in Greenland.

Authors:  Sequssuna Olsen; Dorte Ejg Jarbøl; Mette Kofoed; Kim Abildskov; Michael Lynge Pedersen
Journal:  Int J Circumpolar Health       Date:  2013-02-28       Impact factor: 1.228

8.  Diagnosis and Management of HIV-Associated Pulmonary Diseases in a Ryan White-Funded Primary Care Setting.

Authors:  Kristin R V Harrington; Bashar S Staitieh; Minh Ly T Nguyen; Jonathan A Colasanti; Jieri Sumitani; Vincent C Marconi; Sara C Auld
Journal:  AIDS Patient Care STDS       Date:  2021-07       Impact factor: 5.944

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.